|1.||Wang, Dao-Wen: 1 article (02/2009)|
|2.||Jiang, Jian-Gang: 1 article (02/2009)|
|3.||Fu, Xiang-Ning: 1 article (02/2009)|
|4.||Chen, Chun-Lian: 1 article (02/2009)|
|5.||Goodwill, Adam G: 1 article (09/2007)|
|6.||Stapleton, Phoebe A: 1 article (09/2007)|
|7.||James, Milinda E: 1 article (09/2007)|
|8.||Frisbee, Jefferson C: 1 article (09/2007)|
|9.||Cheng, Gang: 1 article (03/2006)|
|10.||Hao, Bingtao: 1 article (03/2006)|
02/01/2009 - "Expression of cytochrome P450 arachidonic acid epoxygenase 2J2 in human tumor tissues and cell lines."
03/01/2006 - "Human cytochrome P450 2J2 (CYP2J2) is the major arachidonic acid epoxygenase that plays important roles in the pathogenesis of a variety of diseases such as cardiovascular disorders and cancers, this P450 also plays a role in the metabolism of some antihistamine drugs. "
01/01/1997 - "Cytochrome P450 arachidonic acid epoxygenase and omega-hydroxylase activities were markedly reduced in the tumor tissues, whereas, in the juxtatumor tissue, cytochrome P450 omega-hydroxylase activity was significantly increased. "
09/01/2007 - "Using apolipoprotein E (ApoE) and low-density lipoprotein receptor (LDLR) gene deletion male mouse models of hypercholesterolemia at 20 wk of age, we tested the hypothesis that arteriolar dilation would be maintained due to an increased stimulus-induced production of dilator metabolites via cyclooxygenase and cytochrome P-450 epoxygenase pathways. "
|5.||Hepatocellular Carcinoma (Hepatoma)
|1.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|2.||Alkane 1-Monooxygenase (Alkane 1 Monooxygenase)
|3.||Messenger RNA (mRNA)
|4.||LDL Receptors (LDL Receptor)
|5.||Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
|6.||Apolipoproteins E (ApoE)